02.05.2013
- Sanofi is stepping up the development of a fixed combination of diabetes treatments Lantus and Lyxumia to sidestep an earlier setback with a similar pen device and take advantage...
01.05.2013
- Denmark's Novo Nordisk could see the U.S. launch of its biggest drug hope, a new long-acting insulin, delayed until 2018 while it conducts more tests to satisfy regulators, it said...
11.04.2013
- The Rise Of Generics - In 2011, CMS Pharma was invited to take part in a conference in Mumbai to discuss the emergence of "supergenerics," a new form of generic drugs with improved...
22.03.2013
- European regulators have recommended approval of two new multiple sclerosis pills from Biogen and Sanofi, both of which are expected to become major sellers. Friday's decision by...
19.03.2013
- Drug sales will shrink further in France this year as government austerity measures curb healthcare spending in Europe's second-biggest drugs market, a study said on Tuesday. The...
18.03.2013
- Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers scented an opportunity and raced to develop new medicines...
12.02.2013
- For pharmaceutical companies, Africa is changing. Not only is the continent's economic growth grabbing attention in boardrooms but the shifting nature of its disease burden is...
11.02.2013
- Regeneron Pharmaceuticals said its longtime drug-development partner Sanofi aims to boost its stake in the U.S. biotechnology company through open market purchases of its stock...
